US 9193740
Bismacrocyclic compounds as hepatitis C virus inhibitors
granted A61KA61K31/495A61K45/06
Quick answer
US patent 9193740 (Bismacrocyclic compounds as hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/495, A61K45/06, A61P, A61P31/12